Breast/lungcancer
1 – 10 of 143
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Gene expression-based identification of prognostic markers in lung adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Advanced organoid models for targeting Kras-driven lung adenocarcinoma in drug discovery and combination therapy
(
- Contribution to journal › Article
-
Mark
Copy number signatures in cervical samples enable early detection of high-grade serous ovarian carcinoma
2025) SCRM 2025 - the 7th Swedish Cancer Research Meeting(
- Contribution to conference › Poster
-
Mark
Intrathecal pemetrexed for leptomeningeal metastases in a patient with ALK-rearranged lung adenocarcinoma : a case report
(
- Contribution to journal › Article
-
Mark
Timing of Adjuvant Chemotherapy After Surgical Resection for Non-small Cell Lung Cancer : A Target Trial Emulation Using Nationwide Swedish Registry Data
(
- Contribution to journal › Article
-
Mark
Immune Response in Triple-Negative Breast Cancer - Machine Learning-based Insights from Histology and -Omics
2025) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
FHL2 expression by cancer-associated fibroblasts promotes metastasis and angiogenesis in lung adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Global Transcriptional Complexity of Estrogen Receptor Low Positive Breast Cancers in a Prospective Swedish Population-based SCAN-B Cohort
2025) In Clinical cancer research : an official journal of the American Association for Cancer Research 31(13). p.2695-2709(
- Contribution to journal › Article
-
Mark
Genomic characterization of the HER2-enriched intrinsic molecular subtype in primary ER-positive HER2-negative breast cancer
(
- Contribution to journal › Article
-
Mark
The DNA methylation landscape of primary triple-negative breast cancer
(
- Contribution to journal › Article